📣 VC round data is live. Check it out!
- Public Comps
- Japan Lifeline
Japan Lifeline Valuation Multiples
Discover Japan Lifeline's revenue and EBITDA valuation multiples and investment history, alongside public comparables like NeuroPace, Sofwave Medical, Beta Bionics, Tactile Medical and more.
Japan Lifeline Overview
About Japan Lifeline
Japan Lifeline Co Ltd is a medical device company operating in Japan. It is engaged in the trading and manufacturing of medical devices specialized in the cardiovascular field. The company offers medical devices mainly for the treatment of cardiac and vascular diseases. It focuses on providing implantable devices to treat arrhythmias; disposable catheter devices with electrodes for diagnosis and treatment of arrhythmias; prosthetic devices to replace blood vessels and heart valves that lost their functions; and devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities and congenital cardiac diseases.
Founded
1981
HQ

Employees
1.2K
Website
Financials (LTM)
EV
$502M
Valuation Multiples
Start free trialJapan Lifeline Financials
Japan Lifeline reported last 12-month revenue of $380M and EBITDA of $89M.
In the same LTM period, Japan Lifeline generated $224M in gross profit, $89M in EBITDA, and $59M in net income.
Revenue (LTM)
Japan Lifeline P&L
In the most recent fiscal year, Japan Lifeline reported revenue of $355M and EBITDA of $87M.
Japan Lifeline is profitable as of last fiscal year, with gross margin of 60%, EBITDA margin of 24%, and net margin of 16%.
Financial data powered by Morningstar, Inc.
Japan Lifeline Stock Performance
Japan Lifeline has current market cap of $561M, and enterprise value of $502M.
Market Cap Evolution
Japan Lifeline's stock price is $8.00.
Japan Lifeline share price decreased by 4.0% in the last 30 days, and by 15.0% in the last year.
Japan Lifeline has an EPS (earnings per share) of $0.83.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $502M | $561M | -1.6% | -4.0% | -7.2% | -15.0% | $0.83 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialJapan Lifeline Valuation Multiples
Japan Lifeline trades at 1.3x EV/Revenue multiple, and 5.6x EV/EBITDA.
EV / Revenue (LTM)
Japan Lifeline Financial Valuation Multiples
As of June 3, 2026, Japan Lifeline has market cap of $561M and EV of $502M.
Japan Lifeline has a P/E ratio of 9.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Japan Lifeline Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Japan Lifeline Margins & Growth Rates
Japan Lifeline grew revenue by 7% and EBITDA by 5% in the last fiscal year.
In the most recent fiscal year, Japan Lifeline reported gross margin of 60%, EBITDA margin of 24%, and net margin of 16%.
Japan Lifeline Margins
Japan Lifeline Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Japan Lifeline Operational KPIs
Japan Lifeline's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Japan Lifeline's Rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Japan Lifeline's Rule of X is 31% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Japan Lifeline Competitors
Japan Lifeline competitors include NeuroPace, Sofwave Medical, Beta Bionics, Tactile Medical, Bioventus, Polynovo, Cytek Biosciences, Cerus, IBA Group and Mesa Laboratories.
Most Japan Lifeline public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 5.7x | 5.7x | (114.3x) | (86.6x) | |||
| 6.0x | - | 68.7x | - | |||
| 3.8x | 3.3x | (7.1x) | (5.9x) | |||
| 1.4x | 1.4x | 10.6x | 10.1x | |||
| 1.4x | 1.3x | 6.8x | 6.7x | |||
| 5.9x | 5.0x | 72.0x | 57.2x | |||
| 1.5x | 1.5x | (463.4x) | (186.0x) | |||
| 2.4x | 2.3x | 58.8x | 40.6x | |||
This data is available for Pro users. Sign up to see all Japan Lifeline competitors and their valuation data. Start Free Trial | ||||||
Investments by Japan Lifeline
Japan Lifeline has invested in 2 companies to date.
Latest investment by Japan Lifeline was on June 28th 2022. Japan Lifeline invested in Metcela in their $14M Series C round (EV/Revenue multiple available to Pro users).
Latest Investments by Japan Lifeline
| Description | - | - | - | AI Medical Service is a Japanese startup developing AI software incorporating expertise from endoscopic specialists. The technology aids global advancements in endoscopic diagnostics and procedures. | |
| HQ Country | |||||
| HQ City | - | - | - | Tokyo | |
| Deal Date | 28 Jun 2022 | 4 Jan 2021 | 18 Mar 2020 | 4 Oct 2019 | |
| Round | Series C | Series B | Series B | Series B | |
| Raised | $14M | $13M | $4M | $43M | |
| Investors | Cyberdyne; Japan Lifeline; Reazon Holdings; Sony Innovation Fund | Alfresa Holdings; Dai-ichi Life; Eight Roads Ventures; F-Prime; Japan Lifeline; KSP; MAKOTO Capital; Sony Innovation Fund; Tsukuba Exceed Fund; UTEC-The University of Tokyo Edge Capital Partners | Japan Lifeline; Sony Innovation Fund; Tsukuba Exceed Fund | Aflac Global Ventures; Daiwa Corporate Investment; Globis Capital Partners; Innovation Growth Ventures; Japan Lifeline; Japan Post Capital; Ryoyo Electro Corporation; SMBC Venture Capital; Sony Innovation Fund; SparX Group; World Innovation Lab | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Japan Lifeline investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Japan Lifeline
| When was Japan Lifeline founded? | Japan Lifeline was founded in 1981. |
| Where is Japan Lifeline headquartered? | Japan Lifeline is headquartered in Japan. |
| How many employees does Japan Lifeline have? | As of today, Japan Lifeline has over 1K employees. |
| Who is the CEO of Japan Lifeline? | Japan Lifeline's CEO is Keisuke Suzuki. |
| Is Japan Lifeline publicly listed? | Yes, Japan Lifeline is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Japan Lifeline? | Japan Lifeline trades under 7575 ticker. |
| When did Japan Lifeline go public? | Japan Lifeline went public in 1997. |
| Who are competitors of Japan Lifeline? | Japan Lifeline main competitors include NeuroPace, Sofwave Medical, Beta Bionics, Tactile Medical, Bioventus, Polynovo, Cytek Biosciences, Cerus, IBA Group, Mesa Laboratories. |
| What is the current market cap of Japan Lifeline? | Japan Lifeline's current market cap is $561M. |
| What is the current revenue of Japan Lifeline? | Japan Lifeline's last 12 months revenue is $380M. |
| What is the current revenue growth of Japan Lifeline? | Japan Lifeline revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Japan Lifeline? | Current revenue multiple of Japan Lifeline is 1.3x. |
| What is the current EBITDA of Japan Lifeline? | Japan Lifeline's last 12 months EBITDA is $89M. |
| What is Japan Lifeline's EBITDA margin? | Japan Lifeline's last 12 months EBITDA margin is 24%. |
| What is the current EV/EBITDA multiple of Japan Lifeline? | Current EBITDA multiple of Japan Lifeline is 5.6x. |
| What is the current FCF of Japan Lifeline? | Japan Lifeline's last 12 months FCF is $39M. |
| What is Japan Lifeline's FCF margin? | Japan Lifeline's last 12 months FCF margin is 10%. |
| What is the current EV/FCF multiple of Japan Lifeline? | Current FCF multiple of Japan Lifeline is 12.9x. |
| How many companies Japan Lifeline has acquired to date? | Japan Lifeline hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Japan Lifeline has invested to date? | As of June 2026, Japan Lifeline has invested in 2 companies. |
| What was the last Japan Lifeline investment? | On 28th June 2022 Japan Lifeline invested in Metcela, participating in a $14M Series C round, alongside Cyberdyne, Reazon Holdings, and Sony Innovation Fund. |
| In what companies Japan Lifeline invested in? | Japan Lifeline invested in AI Medical Service and Metcela. |
See public comps similar to Japan Lifeline
Lists including Japan Lifeline
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
